share_log

S-3: Registration statement for specified transactions by certain issuers

S-3: Registration statement for specified transactions by certain issuers

S-3：特定交易註冊聲明
美股SEC公告 ·  08/02 16:10
Moomoo AI 已提取核心訊息
SeaStar Medical Holding Corporation, a Delaware-based company, has filed a registration statement with the Securities and Exchange Commission (SEC) on August 2, 2024, for a Form S-3 registration. This filing pertains to the potential sale of up to 1,014,219 shares of common stock by certain selling securityholders. These shares are issuable upon the exercise of previously issued warrants. The registration allows these securityholders to resell their shares in the public market. SeaStar Medical will not receive any proceeds from the sale of these shares, but will receive the exercise price of the warrants unless they are exercised on a cashless basis. The company will bear all expenses related to the registration of the shares. The selling securityholders may sell their shares through various methods including on exchanges, in the over-the-counter market, or through private transactions. The registration statement also includes indemnification agreements for directors and officers, and details on the legal and accounting costs associated with the registration.
SeaStar Medical Holding Corporation, a Delaware-based company, has filed a registration statement with the Securities and Exchange Commission (SEC) on August 2, 2024, for a Form S-3 registration. This filing pertains to the potential sale of up to 1,014,219 shares of common stock by certain selling securityholders. These shares are issuable upon the exercise of previously issued warrants. The registration allows these securityholders to resell their shares in the public market. SeaStar Medical will not receive any proceeds from the sale of these shares, but will receive the exercise price of the warrants unless they are exercised on a cashless basis. The company will bear all expenses related to the registration of the shares. The selling securityholders may sell their shares through various methods including on exchanges, in the over-the-counter market, or through private transactions. The registration statement also includes indemnification agreements for directors and officers, and details on the legal and accounting costs associated with the registration.
總部位於特拉華州的SeaStar Medical Holding Corporation於2024年8月2日向證券交易委員會（SEC）提交了S-3表格的註冊聲明，以申請登記。本註冊申請涉及某些出售證券持有人可能出售高達1,014,219股普通股的情況。這些股份是在先前發行的認股權行權後發行的。該註冊允許這些證券持有人在公開市場上轉售其股票。SeaStar Medical將不會從這些股份的銷售中獲得任何收益，但將收到認股權的行權價格，除非以現金無償方式行權。該公司將承擔與股份登記相關的所有費用。出售證券持有人可以通過各種渠道銷售其股份，包括在交易所、場外市場或私人交易中出售。註冊聲明還包括董事和高管的賠償協議以及與註冊相關的法律和會計費用的詳細信息。
總部位於特拉華州的SeaStar Medical Holding Corporation於2024年8月2日向證券交易委員會（SEC）提交了S-3表格的註冊聲明，以申請登記。本註冊申請涉及某些出售證券持有人可能出售高達1,014,219股普通股的情況。這些股份是在先前發行的認股權行權後發行的。該註冊允許這些證券持有人在公開市場上轉售其股票。SeaStar Medical將不會從這些股份的銷售中獲得任何收益，但將收到認股權的行權價格，除非以現金無償方式行權。該公司將承擔與股份登記相關的所有費用。出售證券持有人可以通過各種渠道銷售其股份，包括在交易所、場外市場或私人交易中出售。註冊聲明還包括董事和高管的賠償協議以及與註冊相關的法律和會計費用的詳細信息。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

獨立文件3  查看翻譯

獨立文件4  查看翻譯

獨立文件5  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息